Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 4

Results For "commercialization"

519 News Found

JP Nadda highlights India’s push for APIs, biologics and translational research
Policy | May 01, 2026

JP Nadda highlights India’s push for APIs, biologics and translational research

On his visit to NIPER Mohali, union health minister vreviews biopharma research initiatives and calls for stronger industry collaboration and commercialization focus


Huwel Lifesciences, ASMS expand into Southeast Asia with Singapore partner
Supply Chain | April 27, 2026

Huwel Lifesciences, ASMS expand into Southeast Asia with Singapore partner

Collaboration to drive diagnostics exports, tap high-growth regional markets and build scalable commercialization platform


ECI taps industry veteran Khalid Raja to drive strategic growth
People | April 22, 2026

ECI taps industry veteran Khalid Raja to drive strategic growth

Move comes amid rising regulatory pressures


Asahi Kasei seals Aicuris acquisition to bolster infectious disease pharma push
Biopharma | April 22, 2026

Asahi Kasei seals Aicuris acquisition to bolster infectious disease pharma push

The deal the group says marks a decisive push deeper into severe infectious diseases and the build-out of a global specialty pharmaceuticals platform


GE HealthCare expands DeepHealth AI partnership to supercharge breast cancer detection
Medical Device | April 20, 2026

GE HealthCare expands DeepHealth AI partnership to supercharge breast cancer detection

The move aims to accelerate the development, commercialization, and global rollout of advanced AI-powered mammography tools


DKSH and Sanofi join forces to expand access to cardio & diabetes treatments in Southeast Asia
Supply Chain | April 17, 2026

DKSH and Sanofi join forces to expand access to cardio & diabetes treatments in Southeast Asia

The aim is to bolster healthcare delivery in a region increasingly burdened by chronic disease


Moberg Pharma reports 2025 annual results, maintains strong cash position
News | April 17, 2026

Moberg Pharma reports 2025 annual results, maintains strong cash position

The company reported net revenue of SEK 13.5 million for the full year 2025


Regeneron and Telix strike major radiopharma pact in push into next-gen cancer therapies
R&D | April 15, 2026

Regeneron and Telix strike major radiopharma pact in push into next-gen cancer therapies

The companies plan to advance multiple solid tumor targets from Regeneron’s antibody portfolio


GoodRx partners with Eli Lilly to expand access to new oral GLP-1 Foundayo & Zepbound KwikPen
News | April 14, 2026

GoodRx partners with Eli Lilly to expand access to new oral GLP-1 Foundayo & Zepbound KwikPen

GoodRx at a starting price of $149 per month—aligned with the lowest available discounted cash price at launch. The rollout includes nationwide pharmacy access


Orbicular, Apotex win tentative USFDA nod for generic Ozempic
Drug Approval | April 11, 2026

Orbicular, Apotex win tentative USFDA nod for generic Ozempic

Hyderabad-based peptide specialist strengthens complex generics credentials as Apotex prepares for U.S. commercialization of semaglutide injection